Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_41A640E3DB01
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT.
Journal
Bone marrow transplantation
Author(s)
Novak U., Mooyaart J.E., Daskalakis M., Scheid C., Gabellier L., Yakoub-Agha I., Ram R., Forcade E., López-Corral L., Nicholson E., Galli E., Stölzel F., Bethge W., Wagner-Drouet E.M., Hoogenboom J.D., Mielke S., Arber C., Simonetta F., Chabannon C., Kuball J., Ruggeri A., Malard F.
ISSN
1476-5365 (Electronic)
ISSN-L
0268-3369
Publication state
In Press
Peer-reviewed
Oui
Language
english
Notes
Publication types: Letter
Publication Status: aheadofprint
OAI-PMH
oai:serval.unil.ch:BIB_41A640E3DB01
DOI
10.1038/s41409-024-02401-4
Pubmed
39192081
Web of science
001299746400002
Create date
30/08/2024 15:18
Last modification date
29/10/2024 7:21
Usage data